论文部分内容阅读
目的：探讨硝苯地平控释片与贝那普利联合对老年高血压治疗的临床效果。方法：选择我院2013年4月至2015年1月收治的86例老年高血压患者为研究对象，随机分为对照组43例，观察组43例，对照组实施贝那普利治疗，观察组实施硝苯地平控释片联合贝那普利治疗，对治疗后效果及安全性进行分析。结果：治疗前，两组患者舒张压与收缩压水平无明显差异，经治疗后，均有明显下降，但是观察组治疗后舒张压与收缩压均较对照组低，差异存在统计学意义（P＜0.05）；观察组不良反应发生率为4.65%，对照组为9.30%，差异无统计学意义（P＞0.05）。结论：老年高血压患者实施硝苯地平控释片联合贝那普利对老年高血压治疗具有显著疗效，可有效控制血压水平，安全性高，值得推广。
Objective: To investigate the clinical effect of combined nifedipine and benazepril on senile hypertension. Methods: A total of 86 elderly hypertensive patients admitted from April 2013 to January 2015 in our hospital were selected and divided into control group (43 cases) and observation group (43 cases). The control group was treated with benazepril and the observation group The implementation of nifedipine controlled release tablets combined with benazepril treatment, the effect and safety after treatment analysis. Results: Before treatment, there was no significant difference between diastolic blood pressure and systolic blood pressure in both groups. After treatment, the diastolic blood pressure and systolic blood pressure were significantly lower than those in the control group (P <0.05). The incidence of adverse reactions was 4.65% in the observation group and 9.30% in the control group, with no significant difference (P> 0.05). Conclusion: Nifedipine controlled release tablets combined with benazepril in senile patients with hypertension have significant curative effect on the treatment of senile hypertension, which can effectively control the blood pressure level, which is safe and worth promoting.